Tim Forshew

Granta Park
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.

Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.

Journal: British journal of cancer
Published: May 09, 2021

Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC).

Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC).

Journal: Journal for immunotherapy of cancer
Published: March 02, 2021

CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma.

CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma.

Journal: Neuropathology and applied neurobiology
Published: October 18, 2019

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Journal: EMBO molecular medicine
Published: June 01, 2018

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.

Journal: PloS one
Published: November 09, 2017

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

Journal: PloS one
Published: August 25, 2017

Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours.

Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours.

Journal: Acta neuropathologica
Published: August 09, 2017

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.

Journal: Nature communications
Published: June 06, 2017

Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.

Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection.

Journal: Cancer medicine
Published: April 05, 2017

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.

Journal: Scientific reports
Published: March 20, 2017

MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma.

MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma.

Journal: Development (Cambridge, England)
Published: February 13, 2017

Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.

Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells.

Journal: Nature medicine
Published: July 26, 2016
Showing 1-12 of 25

Last Updated: 09/26/2026